0 CHECKOUT
Hepatitis Drugs Markets in China - Product Image

Hepatitis Drugs Markets in China

  • ID: 1022811
  • May 2015
  • Region: China
  • 170 pages
  • AMID Co
China's demand for Hepatitis Drugs will continue to grow at about 8% by 2024.

China's demand for Hepatitis Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and READ MORE >

Note: Product cover images may vary from those shown

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

Hepatitis Drugs Industry Structure
Market Size
Market Growth Drivers
Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations and Sales Volumes
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

Overview
Sales Volumes of Hepatitis Drugs by Region
Hepatitis Drugs Sales Volumes
Liver Protection Drugs
Nucleoside Drugs
Interferon (IFN)
Other Hepatitis Drugs
Hepatitis Drugs Imports and Exports
Hepatitis Drugs Imports
Hepatitis Drugs Exports
Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK

Hepatitis Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
China's Distribution System
Hepatitis Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises

VII. HEPATITIS DRUGS PRODUCER DIRECTORY

Hepatitis Drugs Producer Profiles

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations
Major Hepatitis Drugs Producer Sales Volumes
Market Share of Key Producers
Major Foreign Investments in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

Hepatitis Drugs Sales Volumes
Sales Volumes of Hepatitis Drugs by Region
Major Liver Protection Drugs Producer Sales Volumes
Liver Protection Drugs Sales Volumes
Major Nucleoside Drugs Producer Sales Volumes
Nucleoside Drugs Sales Volumes
Major IFN Drugs Producer Sales Volumes
Interferon (IFN) Sales Volumes
Other Hepatitis Drugs Sales Volumes
China Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

Total hepatitis Drugs Sales Volumes by Market
Hepatitis Drugs Sales Volumes and Market Share
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

China’s Hepatitis Drugs Sales Volumes

II. BUSINESS ENVIRONMENT

China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

Hepatitis Drugs Sales Volumes in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

Total Hepatitis Drugs Sales Volumes
Total Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

Hepatitis Drugs Sales Volumes by Market

VI. MARKETING STRATEGIES

China’s Distribution Channel

Note: Product cover images may vary from those shown

- Shenzhen Kexing Biotech Co., Ltd.
- The United Laboratories (Zhuhai) Pharmaceutical Co., Ltd.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S